Kindred Biosciences, Inc. Gains 23.71%
Thu, Jun 03, 2021 at 05:30 PM
Kindred Biosciences, Inc. (KIN:NASDAQ) soared at $6.73, a gain of 23.7%. On Wed, Jun 02, 2021, KIN:NASDAQ hit a New 2-Week High of $5.44. The stock appeared on our News Catalysts scanner on Thu, Jun 03, 2021 at 10:21 AM in the 'MISCELLANEOUS' category. From Wed, May 19, 2021, the stock recorded 66.67% Up Days and 30.00% Green Days
The stock spiked on Thu, Jan 28, 2021 at $6 with a volume of 2M+, and its share price has been moving sideways in recent weeks.
About Kindred Biosciences, Inc. (KIN:NASDAQ)
Kindred Biosciences Inc is a development-stage biopharmaceutical company. It is engaged in saving and improving the lives of pets. The Company's product candidates are SentiKind, KIND-010 and KIND-012.
Top 10 Gainers:
- Adamis Pharmaceuticals Corporation (ADMP:NASDAQ), 61.43%
- GTT Communications, Inc. (GTT:NYSE), 39.6%
- Energy Focus, Inc. (EFOI:NASDAQ), 35.43%
- The InterGroup Corporation (INTG:NASDAQ), 30.08%
- Workhorse Group Inc. (WKHS:NASDAQ), 28.21%
- Conn's, Inc. (CONN:NASDAQ), 27.32%
- Kindred Biosciences, Inc. (KIN:NASDAQ), 23.71%
- PYR (PYR:NASDAQ), 23.35%
- SemiLEDs Corporation (LEDS:NASDAQ), 23.27%
- Q&K International Group Limited (QK:NASDAQ), 22.95%